Business Wire | Apr 28, 2021 06:45AM EDT

Helen of Troy Limited Reports Fourth Quarter Fiscal 2021 Results

Apr. 28, 2021

EL PASO, Texas--(BUSINESS WIRE)--Apr. 28, 2021--Helen of Troy Limited (NASDAQ: HELE), designer, developer and worldwide marketer of consumer brand-name housewares, health and home, and beauty products, today reported results for the three-month period ended February 28, 2021.

Executive Summary - Fourth Quarter of Fiscal 2021

* Consolidated net sales revenue increase of 15.1% to $509.4 million, including: An adverse impact from February Winter Storm Uri of approximately $15 million, or 3.4% An increase in Leadership Brand net sales of 20.2% An increase in online channel net sales of approximately 30% Organic business net sales growth of 12.2% Core business net sales growth of 16.2%

* GAAP consolidated operating income of $24.5 million, or 4.8% of net sales, which includes a non-cash asset impairment charge of $8.5 million, compared to a GAAP operating loss of $2.7 million, or 0.6% of net sales, for the same period last year, which included acquisition-related expenses of $1.1 million, non-cash asset impairment charges of $41.0 million, and restructuring charges of $2.3 million

* Non-GAAP consolidated adjusted operating income decrease of 20.5% to $42.9 million, or 8.4% of net sales, compared to $53.9 million, or 12.2% of net sales, for the same period last year

* GAAP diluted EPS of $0.90, which includes a non-cash asset impairment charge of $0.30 per share, compared to a GAAP diluted loss per share of $0.13 for the same period last year, which included acquisition-related expenses of $0.04 per share, non-cash asset impairment charges of $1.43 per share, and restructuring charges of $0.08 per share

* Non-GAAP adjusted diluted EPS of $1.57 despite an adverse winter storm impact of approximately $0.20, compared to $1.88 for the same period last year

Executive Summary - Fiscal 2021

* Consolidated net sales revenue increase of 22.9% including: An increase in Leadership Brand net sales of 25.5% An increase in online channel net sales of approximately 32% Organic business net sales growth of 20.3% Core business net sales growth of 23.7%

* GAAP consolidated operating income of $281.5 million, or 13.4% of net sales, which includes a non-cash asset impairment charge of $8.5 million and restructuring charges of $0.4 million, compared to $178.3 million, or 10.4% of net sales, for the same period last year, which included acquisition-related expenses of $2.5 million, non-cash asset impairment charges of $41.0 million, and restructuring charges of $3.3 million

* Non-GAAP consolidated adjusted operating income increase of 24.2% to $334.4 million, or 15.9% of net sales, compared to $269.3 million, or 15.8% of net sales, for the same period last year

* GAAP diluted EPS of $10.08, which includes a non-cash asset impairment charge of $0.30 per share, restructuring charges of $0.01 per share, and a benefit from tax reform of $0.37 per share, compared to $6.02 for the same period last year, which included acquisition-related expenses of $0.10 per share, non-cash asset impairment charges of $1.44 per share, and restructuring charges of $0.12 per share

* Non-GAAP adjusted diluted EPS increase of 25.3% to $11.65, compared to $9.30 for the same period last year

* Net cash provided by operating activities growth of 15.8% to $314.1 million, compared to $271.3 million for the same period last year

* Free cash flow of $215.4 million, which includes a one-time, up-front license fee payment of $72.5 million to extend the license of Revlon's trademark for hair care appliances and tools, royalty-free for the next 100 years, compared to $253.5 million for the same period last year

* Repurchased 960,829 shares of common stock in the open market during the fiscal year for $191.6 million, at an average price of $199.42 per share

Julien R. Mininberg, Chief Executive Officer, stated: "Our fourth quarter results cap off an extraordinary year for Helen of Troy and an outstanding second year of our Phase II Transformation. I am very proud of the agility our organization demonstrated as we worked together with even more passion to address COVID-19's unprecedented challenges to all aspects of the business. These efforts drove us past the $2 billion sales milestone, grew our market share for several key brands, and delivered outstanding operating cash flow, adjusted operating income, and adjusted EPS growth in fiscal 2021. During the year, our Leadership Brands once again led the way, now making up more than 81% of our sales and online sales grew to now represent 26% of total sales. Our strategic focus on international continued to bear fruit. The diversified nature of our portfolio provided consistency, with some categories benefiting from changed consumer behavior and some of our categories posting another year of strong growth based on the timeless power of consumer-centric innovation and outstanding execution. We were not shy about using this strength to further invest in projects intended to power our value creation flywheel, such as new product innovations for fiscal 2022 and beyond, IT, Direct-to-Consumer, expanded production and distribution capacity, and investments in much healthier inventory levels."

"As we look to fiscal 2022, our all-weather portfolio of Leadership Brands is well suited to continue serving consumers. As COVID-19 lingers it favors our health-related brands. Other brands such as Hydro Flask, Drybar, Revlon, and HOT Tools are expected to benefit further as the post-pandemic landscape takes shape, and OXO is positioned to succeed in most environments. We have taken steps to address the uncertainties from the continued path of COVID-19 and emerging inflationary environment. We are working with our supply chain partners and have implemented cost mitigation measures to help offset expected inflation and will make pricing decisions to further address the situation as it evolves. We believe these actions will help us deliver on our Phase II average annual growth targets from our new elevated base and that adjusted EPS growth in fiscal 2022 is achievable. Our balance sheet has never been stronger, and we have ample liquidity and operational capability to fuel growth with a combination of organic expansion and acquisition. We believe our key strategic initiatives position us well to create significant additional shareholder value over the course of the remaining three years of Phase II."

Three Months Ended Last Day of February,

(in thousands) Housewares Health & Beauty Total Home

Fiscal 2020 sales revenue, $ 144,948 $ 185,854 $ 111,563 $ 442,365 net

Organic business (1) 17,113 40,648 (3,836) 53,925

Impact of foreign currency 402 2,121 195 2,718

Acquisition (2) - - 10,367 10,367

Change in sales revenue, net 17,515 42,769 6,726 67,010

Fiscal 2021 sales revenue, $ 162,463 $ 228,623 $ 118,289 $ 509,375 net



Total net sales revenue 12.1 % 23.0 % 6.0 % 15.1 %growth (decline)

Organic business 11.8 % 21.9 % (3.4) % 12.2 %

Impact of foreign currency 0.3 % 1.1 % 0.2 % 0.6 %

Acquisition - % - % 9.3 % 2.3 %



Operating margin (GAAP)

Fiscal 2021 10.0 % (0.7) % 8.5 % 4.8 %

Fiscal 2020 9.6 % 8.8 % (29.6) % (0.6) %

Adjusted operating margin (non-GAAP)

Fiscal 2021 11.7 % 0.7 % 18.9 % 8.4 %

Fiscal 2020 11.8 % 11.2 % 14.4 % 12.2 %

Consistent with its strategy of focusing on its Leadership Brands, the Company committed to a plan to divest certain assets within its global mass channel personal care business ("Personal Care"). The assets to be divested include intangible assets, inventory, net trade receivables and fixed assets related to the Company's mass channel liquids, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium. The Company entered into exclusive negotiations with a selected bidder at the end of February and have largely agreed to the broader terms. The Company is currently working through the detailed negotiation of the various agreements and complexities needed to complete the transaction and hopes to have more to announce very soon. The Company defines Core as strategic business that it expects to be an ongoing part of its operations, and Non-Core as business or assets (including assets held for sale) that it expects to divest within a year of its designation as Non-Core.

Three Months Ended Last Day of February,

(in thousands) Housewares Health & Beauty Total Home

Fiscal 2020 sales revenue, $ 144,948 $ 185,854 $ 111,563 $ 442,365 net

Core business (3) 17,515 42,769 11,534 71,818

Non-Core business (Personal - - (4,808) (4,808) Care) (3)

Change in sales revenue, net 17,515 42,769 6,726 67,010

Fiscal 2021 sales revenue, $ 162,463 $ 228,623 $ 118,289 $ 509,375 net



Total net sales revenue 12.1 % 23.0 % 6.0 % 15.1 %growth (decline)

Core business 12.1 % 23.0 % 10.3 % 16.2 %

Non-Core business (Personal - % - % (4.3) % (1.1) %Care)

Consolidated Results - Fourth Quarter Fiscal 2021 Compared to Fourth Quarter Fiscal 2020

* Consolidated net sales revenue increased $67.0 million, or 15.1% to $509.4 million compared to $442.4 million. The growth was driven by an Organic business increase of $53.9 million, or 12.2%, primarily reflecting growth in online, international, and brick and mortar channel sales. The Drybar Products acquisition also contributed $10.4 million of incremental net sales revenue for the eight week period prior to the first anniversary of the acquisition. These factors were partially offset by the adverse impact from February Winter Storm Uri which prevented the Company from shipping approximately $15 million of orders before the end of the quarter, COVID-19 related store traffic declines at certain retail customers and a decline in Non-Core business.

* Consolidated gross profit margin increased 1.7 percentage points to 45.2%, compared to 43.5%. The increase was primarily due to a more favorable channel mix within the Housewares segment, a more favorable product mix within the Organic Beauty business and Health & Home segment, and the favorable impact of the Drybar Products acquisition. These factors were partially offset by an unfavorable product mix within the Housewares segment and higher inbound freight expense.

* Consolidated selling, general and administrative expense ("SG&A") ratio increased 4.3 percentage points to 38.7%, compared to 34.4%. The increase was primarily due to higher marketing and new product development expense, increased freight and distribution expense, and higher legal, patent defense and other professional fees. These factors were partially offset by favorable operating leverage, reduced royalty expense as a result of the extension of the Revlon trademark license, lower amortization expense, and travel expense reductions due to COVID-19.

* Consolidated operating income was $24.5 million, or 4.8% of net sales revenue, compared to an operating loss of $2.7 million, or 0.6% of net sales revenue. The increase in consolidated operating margin was primarily due to a higher gross profit margin and the comparative impact of lower non-cash asset impairment charges year-over-year. These factors were partially offset by an increase in the SG&A ratio.

* Income tax benefit as a percentage of income before tax was 2.7%, compared to income tax benefit as a percentage of loss before tax of 48.1%. The year-over-year change was primarily due to the comparative impact of tax benefits recognized on impairment charges recorded in both periods.

* Net Income was $22.2 million, or $0.90 per diluted share, compared to a net loss of $3.2 million, or $0.13 per diluted share. Diluted EPS improved primarily due to higher operating income in the Beauty segment, which includes the favorable comparative impact of lower after-tax non-cash asset impairment charges, restructuring charges and acquisition-related expenses year-over-year, higher operating income in the Housewares segment, and the favorable impact of lower weighted average diluted shares outstanding. These factors were partially offset by an adverse impact of approximately $0.20 per diluted share from Winter Storm Uri, reduced operating income in the Health & Home segment and a lower income tax benefit.

* Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) decreased 16.8% to $48.6 million compared to $58.4 million.

On an adjusted basis for the fourth quarters of fiscal 2021 and 2020, excluding acquisition-related expenses, non-cash asset impairment charges, restructuring charges, amortization of intangible assets, and non-cash share-based compensation, as applicable:

* Adjusted operating income decreased $11.1 million, or 20.5%, to $42.9 million, or 8.4% of net sales revenue, compared to $53.9 million, or 12.2% of net sales revenue. The 3.8 percentage point decrease in adjusted operating margin primarily reflects an unfavorable product mix within the Housewares segment, higher marketing and new product development expense, higher inbound and outbound freight and distribution expense, and higher legal, patent defense and other professional fees. These factors were partially offset by favorable operating leverage, a more favorable product mix within the Organic Beauty business and Health & Home segment, favorable channel mix within the Housewares segment, and travel expense reductions due to COVID-19.

* Adjusted income decreased $9.1 million, or 19.0%, to $38.8 million, compared to $47.8 million. Adjusted diluted EPS decreased 16.5% to $1.57, compared to $1.88. The decrease in adjusted diluted EPS was primarily due to an adverse impact of approximately $0.20 per diluted share from Winter Storm Uri and reduced operating income in the Health & Home segment. These factors were partially offset by higher operating income in the Beauty and Housewares segments, and the favorable impact of lower weighted average diluted shares outstanding.

Segment Results - Fourth Quarter Fiscal 2021 Compared to Fourth Quarter Fiscal 2020

Housewares net sales revenue increased $17.5 million, or 12.1%, to $162.5 million, compared to $144.9 million. The increase was driven by an Organic business increase of $17.1 million, or 11.8%, primarily due to higher demand for OXO brand products as COVID-19 continued to keep consumers at home cooking, baking and organizing, which resulted in increases in online, brick and mortar, and international sales. These factors were partially offset by an adverse impact from Winter Storm Uri, the COVID-19 related impact of reduced store traffic at certain retail brick and mortar stores, increased competitive activity and strong new product releases in the prior year period. Operating income increased 16.0% to $16.2 million, or 10.0% of segment net sales revenue, compared to $14.0 million, or 9.6% of segment net sales revenue. The 0.4 percentage point increase was primarily due to favorable operating leverage, a more favorable channel mix, lower marketing expenses, and travel expense reductions due to COVID-19. These factors were partially offset by a less favorable product mix, higher inbound and outbound freight and distribution expense, and higher annual incentive compensation. Adjusted operating income increased 10.7% to $19.0 million, or 11.7% of segment net sales revenue, compared to $17.1 million, or 11.8% of segment net sales revenue.

Health & Home net sales revenue increased $42.8 million, or 23.0%, to $228.6 million, compared to $185.9 million. The increase was driven by an Organic business increase of $40.6 million, or 21.9%, primarily due to continued strong consumer demand for healthcare and healthy living products in domestic and international markets, primarily in thermometry and air purification, in both brick and mortar and online channels, mainly attributable to COVID-19. These factors were partially offset by declines in non-strategic product categories, a far below average cough/cold/flu season due to social distancing and remote schooling related to COVID-19, and an adverse impact from Winter Storm Uri on end-of-quarter shipments. Operating loss was $1.7 million, or 0.7% of segment net sales revenue, compared to operating income of $16.3 million, or 8.8% of segment net sales revenue. The 9.5 percentage point decrease in segment operating margin was primarily due to increased marketing and new product development expense, higher inbound freight expense, higher distribution costs, higher annual incentive compensation, and increased legal and other professional fees. These factors were partially offset by favorable operating leverage and a more favorable product mix. Adjusted operating income decreased 92.6% to $1.5 million, or 0.7% of segment net sales revenue, compared to $20.8 million, or 11.2% of segment net sales revenue in the same period last year.

Beauty net sales revenue increased $6.7 million, or 6.0%, to $118.3 million, compared to $111.6 million. The increase was driven by the incremental net sales revenue contribution from Drybar Products of $10.4 million, or 9.3% growth, for the eight week period prior to the first anniversary of the acquisition. Sales for the five week period subsequent to the acquisition anniversary date are included in Organic business sales. These factors were partially offset by an Organic business decrease of $3.8 million, or 3.4% due to a decline in Personal Care and an adverse impact from Winter Storm Uri on end-of-quarter shipments. Operating income was $10.0 million, or 8.5% of segment net sales revenue compared to an operating loss of $33.0 million, or 29.6% of segment net sales revenue. The 38.1 percentage point increase in operating margin reflects the favorable comparative impact of lower non-cash asset impairment charges, lower restructuring charges and lower acquisition-related expenses year-over-year. The increase in operating margin also reflects a more favorable product mix, reduced royalty expense as a result of the extension of the Revlon trademark license, lower amortization expense, lower bad debt expense, and travel expense reductions due to COVID-19. These factors were partially offset by increased marketing expense, increased inbound and outbound freight expense, higher personnel expense related to the acquisition of Drybar Products, and higher legal and other professional fees. Adjusted operating income increased 39.6% to $22.4 million, or 18.9% of segment net sales revenue, compared to $16.0 million, or 14.4% of segment net sales revenue.

Balance Sheet and Cash Flow Highlights - Fiscal 2021 Compared to Fiscal 2020

* Cash and cash equivalents totaled $45.1 million, compared to $24.5 million.

* Accounts receivable turnover for fiscal 2021 was 68.6 days, compared to 67.0 days for the same period last year.

* Inventory was $481.6 million, compared to $256.3 million. Inventory turnover for fiscal 2021 was 3.2 times, compared to 3.0 times for the same period last year.

* Total short- and long-term debt was $343.6 million, compared to $339.3 million.

* Net cash provided by operating activities for fiscal 2021 was $314.1 million, compared to $271.3 million.

Fiscal 2022 Business Update

Due to the high level of business uncertainty related to the unpredictable path of the evolving COVID-19 pandemic, ongoing disruption in global supply chains, and the volatility in the cost and availability of commodities, freight and other resources, the Company is not providing an Outlook for fiscal 2022 at this time. The extent of the impact of COVID-19 on the Company's business and financial results will depend largely on future developments that are impossible to predict at this juncture and outside the Company's control, including the duration of the spread of the COVID-19 outbreak, the availability, adoption and effectiveness of the COVID-19 vaccine, the impact on capital and financial markets and the related impact on consumer confidence and spending. Additionally, surges in demand for certain products and shifts in shopping patterns related to COVID-19, as well as other factors, have strained the global freight network, resulting in higher costs, less capacity, and longer lead times across nearly all industries. With continued increases in demand and limited supply for containers, the market rates for inbound freight have increased several fold compared to calendar year 2020 averages. In order to adjust to the difficult and uncertain environment, the Company has implemented a number of mitigation and cost reduction measures that will remain in place until there is greater certainty and less variability. While we have not yet made all our pricing decisions, price increases are being considered, along with our other cost mitigation and reduction strategies.

Conference Call and Webcast

The Company will conduct a teleconference in conjunction with today's earnings release. The teleconference begins at 9:00 a.m. Eastern Time today, Wednesday, April 28, 2021. Investors and analysts interested in participating in the call are invited to dial (877) 407-3982 approximately ten minutes prior to the start of the call. The conference call will also be webcast live at: http://investor.helenoftroy.com. A telephone replay of this call will be available at 12:00 p.m. Eastern Time on April 28, 2021 until 11:59 p.m. Eastern Time on May 5, 2021 and can be accessed by dialing (844) 512-2921 and entering replay pin number 13718414. A replay of the webcast will remain available on the website for one year.

Non-GAAP Financial Measures

The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States of America ("GAAP"). To supplement its presentation, the Company discloses certain financial measures that may be considered non-GAAP such as Adjusted Operating Income, Adjusted Operating Margin, Adjusted Income, Adjusted Diluted Earnings per Share ("EPS"), Core and Non-Core Adjusted Diluted EPS, EBITDA, Adjusted EBITDA, and Free Cash Flow, which are presented in accompanying tables to this press release along with a reconciliation of these financial measures to their corresponding GAAP-based measures presented in the Company's consolidated statements of income and cash flows. For additional information see Note 10 to the accompanying tables to this press release.

About Helen of Troy Limited

Helen of Troy Limited (NASDAQ: HELE) is a leading global consumer products company offering creative products and solutions for its customers through a diversified portfolio of well-recognized and widely-trusted brands, including OXO, Hydro Flask, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar. We sometimes refer to these brands as our Leadership Brands. All trademarks herein belong to Helen of Troy Limited (or its subsidiaries) and/or are used under license from their respective licensors.

For more information about Helen of Troy, please visit http://investor.helenoftroy.com/

Forward-Looking Statements

Certain written and oral statements made by the Company and subsidiaries of the Company may constitute "forward-looking statements" as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this press release. Generally, the words "anticipates", "believes", "expects", "plans", "may", "will", "should", "seeks", "estimates", "project", "predict", "potential", "continue", "intends", and other similar words identify forward-looking statements. All statements that address operating results, events or developments that the Company expects or anticipates will occur in the future, including statements related to sales, earnings per share results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon its current expectations and various assumptions. The Company believes there is a reasonable basis for these expectations and assumptions, but there can be no assurance that the Company will realize these expectations or that these assumptions will prove correct. Forward-looking statements are subject to risks that could cause them to differ materially from actual results. Accordingly, the Company cautions readers not to place undue reliance on forward-looking statements. The forward-looking statements contained in this press release should be read in conjunction with, and are subject to and qualified by, the risks described in the Company's Form 10-K for the year ended February 28, 2021, and in the Company's other filings with the SEC. Investors are urged to refer to the risk factors referred to above for a description of these risks. Such risks include, among others, the Company's ability to successfully manage the demand, supply, and operational challenges associated with the actual or perceived effects of COVID-19 and any similar future public health crisis, pandemic or epidemic, the Company's ability to deliver products to its customers in a timely manner and according to their fulfillment standards, actions taken by large customers that may adversely affect the Company's gross profit and operating results, the Company's dependence on the strength of retail economies and vulnerabilities to any prolonged economic downturn, including from the effects of COVID-19, the Company's dependence on sales to several large customers and the risks associated with any loss of, or substantial decline in, sales to top customers, expectations regarding recent acquisitions and any future acquisitions or divestitures, including the Company's ability to realize related synergies along with its ability to effectively integrate acquired businesses or disaggregate divested businesses, the Company's reliance on its Chief Executive Officer and a limited number of other key senior officers to operate its business, obsolescence or interruptions in the operation of the Company's central global Enterprise Resource Planning ("ERP") systems and other peripheral information systems, occurrence of cyber incidents or failure by the Company or its third-party service providers to maintain cybersecurity and the integrity of confidential internal or customer data, the Company's dependence on third-party manufacturers, most of which are located in the Far East, and any inability to obtain products from such manufacturers, risks associated with weather conditions, the duration and severity of the cold and flu season and other related factors, the geographic concentration and peak season capacity of certain U.S. distribution facilities which increase its risk to disruptions that could affect the Company's ability to deliver products in a timely manner, risks associated with the use of licensed trademarks from or to third parties, the Company's ability to develop and introduce a continuing stream of innovative new products to meet changing consumer preferences, the risks associated with trade barriers, exchange controls, expropriations, and other risks associated with domestic and foreign operations, the risks associated with significant changes in regulations, interpretations or product certification requirements, the risks associated with global legal developments regarding privacy and data security that could result in changes to its business practices, penalties, increased cost of operations, or otherwise harm the business, the risks associated with accounting for tax positions and the resolution of tax disputes, the risks of potential changes in laws and regulations, including environmental, health and safety and tax laws, and the costs and complexities of compliance with such laws, the Company's ability to continue to avoid classification as a Controlled Foreign Corporation, the risks associated with legislation enacted in Bermuda and Barbados in response to the European Union's review of harmful tax competition, the risks of significant tariffs or other restrictions being placed on imports from China or Mexico or any retaliatory trade measures taken by China or Mexico, the risks associated with product recalls, product liability and other claims against the Company, and associated financial risks including but not limited to, significant impairment of the Company's goodwill, indefinite-lived and definite-lived intangible assets or other long-lived assets, risks associated with foreign currency exchange rate fluctuations, increased costs of raw materials, energy and transportation, projections of product demand, sales and net income, which are highly subjective in nature, and from which future sales and net income could vary in a material amount, the risks to the Company's liquidity or cost of capital which may be materially adversely affected by constraints or changes in the capital and credit markets and limitations under its financing arrangements. The Company undertakes no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Statements of Income

(Unaudited) (in thousands, except per share data)

Three Months Ended Last Day of February,

2021 2020

Sales revenue, net $ 509,375 100.0 % $ 442,365 100.0 %

Cost of goods sold 279,037 54.8 % 249,750 56.5 %

Gross profit 230,338 45.2 % 192,615 43.5 %

Selling, general and 197,366 38.7 % 152,108 34.4 %administrative expense ("SG&A")

Asset impairment charges 8,452 1.7 % 41,000 9.3 %

Restructuring charges (5) - % 2,252 0.5 %

Operating income (loss) 24,525 4.8 % (2,745) (0.6) %

Non-operating income, net 119 - % 81 - %

Interest expense 3,049 0.6 % 3,414 0.8 %

Income (loss) before income tax 21,595 4.2 % (6,078) (1.4) %

Income tax benefit (577) (0.1) % (2,923) (0.7) %

Net income (loss) $ 22,172 4.4 % $ (3,155) (0.7) %



Diluted earnings (loss) per share $ 0.90 $ (0.13) ("EPS")



Weighted average shares of commonstock used in computing diluted 24,737 25,175 EPS

Fiscal Year Ended Last Day of February,

2021

2020

Sales revenue, net

$

2,098,799

100.0

%

$

1,707,432

100.0

%

Cost of goods sold

1,171,497

55.8

%

972,966

57.0

%

Gross profit

927,302

44.2

%

734,466

43.0

%

SG&A

637,012

30.4

%

511,902

30.0

%

Asset impairment charges

8,452

0.4

%

41,000

2.4

%

Restructuring charges

350

-

%

3,313

0.2

%

Operating income

281,488

13.4

%

178,251

10.4

%

Non-operating income, net

559

-

%

394

-

%

Interest expense

12,617

0.6

%

12,705

0.7

%

Income before income tax

269,430

12.8

%

165,940

9.7

%

Income tax expense

15,484

0.7

%

13,607

0.8

%

Net income

$

253,946

12.1

%

$

152,333

8.9

%

Diluted EPS

$

10.08

$

6.02

Weighted average shares of common stock used in computing diluted EPS

25,196

25,322

Fiscal Year Ended Last Day of February,

2021 2020

Sales revenue, net $ 2,098,799 100.0 % $ 1,707,432 100.0 %

Cost of goods sold 1,171,497 55.8 % 972,966 57.0 %

Gross profit 927,302 44.2 % 734,466 43.0 %

SG&A 637,012 30.4 % 511,902 30.0 %

Asset impairment charges 8,452 0.4 % 41,000 2.4 %

Restructuring charges 350 - % 3,313 0.2 %

Operating income 281,488 13.4 % 178,251 10.4 %

Non-operating income, net 559 - % 394 - %

Interest expense 12,617 0.6 % 12,705 0.7 %

Income before income tax 269,430 12.8 % 165,940 9.7 %

Income tax expense 15,484 0.7 % 13,607 0.8 %

Net income $ 253,946 12.1 % $ 152,333 8.9 %



Diluted EPS $ 10.08 $ 6.02



Weighted average shares ofcommon stock used in 25,196 25,322 computing diluted EPS

Consolidated Statements of Income and Reconciliation of Non-GAAP Financial Measures - Adjusted Operating Income, Adjusted Income and Adjusted Diluted EPS (2) (10)

(Unaudited) (in thousands, except per share data)

Three Months Ended February 28, 2021

As Reported

(GAAP)

Adjustments

Adjusted

(Non-GAAP)

Sales revenue, net

$

509,375

100.0

%

$

-

$

509,375

100.0

%

Cost of goods sold

279,037

54.8

%

-

279,037

54.8

%

Gross profit

230,338

45.2

%

-

230,338

45.2

%

SG&A

197,366

38.7

%

(4,116)

(4)

187,486

36.8

%

(5,764)

(5)

Asset impairment charges

8,452

1.7

%

(8,452)

(6)

-

-

%

Restructuring charges

(5)

-

%

5

(7)

-

-

%

Operating income

24,525

4.8

%

18,327

42,852

8.4

%

Non-operating income, net

119

-

%

-

119

-

%

Interest expense

3,049

0.6

%

-

3,049

0.6

%

Income before income tax

21,595

4.2

%

18,327

39,922

7.8

%

Income tax (benefit) expense

(577)

(0.1)

%

1,743

1,166

0.2

%

Net Income

$

22,172

4.4

%

$

16,584

$

38,756

7.6

%

Diluted EPS

$

0.90

$

0.67

$

1.57

Weighted average shares of common stock used in computing diluted EPS

24,737

24,737

Consolidated Statements of Income and Reconciliation of Non-GAAP FinancialMeasures -Adjusted Operating Income, Adjusted Income and Adjusted Diluted EPS (2) (10)

(Unaudited) (in thousands, except per share data)

Three Months Ended February 28, 2021

As Reported Adjusted Adjustments (GAAP) (Non-GAAP)

Sales revenue, $ 509,375 100.0 % $ - $ 509,375 100.0 %net

Cost of goods 279,037 54.8 % - 279,037 54.8 %sold

Gross profit 230,338 45.2 % - 230,338 45.2 %

SG&A 197,366 38.7 % (4,116) (4) 187,486 36.8 %

(5,764) (5)

Asset impairment 8,452 1.7 % (8,452) (6) - - %charges

Restructuring (5) - % 5 (7) - - %charges

Operating income 24,525 4.8 % 18,327 42,852 8.4 %

Non-operating 119 - % - 119 - %income, net

Interest expense 3,049 0.6 % - 3,049 0.6 %

Income before 21,595 4.2 % 18,327 39,922 7.8 %income tax

Income tax (577) (0.1) % 1,743 1,166 0.2 %(benefit) expense

Net Income $ 22,172 4.4 % $ 16,584 $ 38,756 7.6 %



Diluted EPS $ 0.90 $ 0.67 $ 1.57



Weighted averageshares of commonstock used in 24,737 24,737 computing dilutedEPS

Three Months Ended February 29, 2020

As Reported

(GAAP)

Adjustments

Adjusted

(Non-GAAP)

Sales revenue, net

$

442,365

100.0

%

$

-

$

442,365

100.0

%

Cost of goods sold

249,750

56.5

%

-

249,750

56.5

%

Gross profit

192,615

43.5

%

-

192,615

43.5

%

SG&A

152,108

34.4

%

(8,142)

(4)

138,709

31.4

%

(4,186)

(5)

(1,071)

(8)

Asset impairment charges

41,000

9.3

%

(41,000)

(6)

-

-

%

Restructuring charges

2,252

0.5

%

(2,252)

(7)

-

-

%

Operating (loss) income

(2,745)

(0.6)

%

56,651

53,906

12.2

%

Non-operating income, net

81

-

%

-

81

-

%

Interest expense

3,414

0.8

%

-

3,414

0.8

%

(Loss) income before income tax

(6,078)

(1.4)

%

56,651

50,573

11.4

%

Income tax (benefit) expense

(2,923)

(0.7)

%

5,676

2,753

0.6

%

Net (loss) income

$

(3,155)

(0.7)

%

$

50,975

$

47,820

10.8

%

Diluted EPS

$

(0.13)

$

2.01

$

1.88

Weighted average shares of common stock used in computing diluted EPS

25,175

25,403

Three Months Ended February 29, 2020

As Reported Adjusted Adjustments (GAAP) (Non-GAAP)

Sales revenue, $ 442,365 100.0 % $ - $ 442,365 100.0 %net

Cost of goods 249,750 56.5 % - 249,750 56.5 %sold

Gross profit 192,615 43.5 % - 192,615 43.5 %

SG&A 152,108 34.4 % (8,142) (4) 138,709 31.4 %

(4,186) (5)

(1,071) (8)

Asset impairment 41,000 9.3 % (41,000) (6) - - %charges

Restructuring 2,252 0.5 % (2,252) (7) - - %charges

Operating (loss) (2,745) (0.6) % 56,651 53,906 12.2 %income

Non-operating 81 - % - 81 - %income, net

Interest expense 3,414 0.8 % - 3,414 0.8 %

(Loss) income (6,078) (1.4) % 56,651 50,573 11.4 %before income tax

Income tax (2,923) (0.7) % 5,676 2,753 0.6 %(benefit) expense

Net (loss) income $ (3,155) (0.7) % $ 50,975 $ 47,820 10.8 %



Diluted EPS $ (0.13) $ 2.01 $ 1.88



Weighted averageshares of commonstock used in 25,175 25,403 computing dilutedEPS

Consolidated Statements of Income and Reconciliation of Non-GAAP Financial Measures - Adjusted Operating Income, Adjusted Income and Adjusted Diluted EPS (2) (10)

(Unaudited) (in thousands, except per share data)

Fiscal Year Ended February 28, 2021

As Reported

(GAAP)

Adjustments

Adjusted

(Non-GAAP)

Sales revenue, net

$

2,098,799

100.0

%

$

-

$

2,098,799

100.0

%

Cost of goods sold

1,171,497

55.8

%

-

1,171,497

55.8

%

Gross profit

927,302

44.2

%

-

927,302

44.2

%

SG&A

637,012

30.4

%

(17,643)

(4)

592,951

28.3

%

(26,418)

(5)

Asset impairment charges

8,452

0.4

%

(8,452)

(6)

-

-

%

Restructuring charges

350

-

%

(350)

(7)

-

-

%

Operating income

281,488

13.4

%

52,863

334,351

15.9

%

Non-operating income, net

559

-

%

-

559

-

%

Interest expense

12,617

0.6

%

-

12,617

0.6

%

Income before income tax

269,430

12.8

%

52,863

322,293

15.4

%

Income tax expense

15,484

0.7

%

13,159

28,643

1.4

%

Net Income

$

253,946

12.1

%

$

39,704

$

293,650

14.0

%

Diluted EPS

$

10.08

$

1.58

$

11.65

Weighted average shares of common stock used in computing diluted EPS

25,196

25,196

Consolidated Statements of Income and Reconciliation of Non-GAAP FinancialMeasures -Adjusted Operating Income, Adjusted Income and Adjusted Diluted EPS (2) (10)

(Unaudited) (in thousands, except per share data)

Fiscal Year Ended February 28, 2021

As Reported Adjusted Adjustments (GAAP) (Non-GAAP)

Sales $ 2,098,799 100.0 % $ - $ 2,098,799 100.0 %revenue, net

Cost of goods 1,171,497 55.8 % - 1,171,497 55.8 %sold

Gross profit 927,302 44.2 % - 927,302 44.2 %

SG&A 637,012 30.4 % (17,643) (4) 592,951 28.3 %

(26,418) (5)

Assetimpairment 8,452 0.4 % (8,452) (6) - - %charges

Restructuring 350 - % (350) (7) - - %charges

Operating 281,488 13.4 % 52,863 334,351 15.9 %income

Non-operating 559 - % - 559 - %income, net

Interest 12,617 0.6 % - 12,617 0.6 %expense

Income before 269,430 12.8 % 52,863 322,293 15.4 %income tax

Income tax 15,484 0.7 % 13,159 28,643 1.4 %expense

Net Income $ 253,946 12.1 % $ 39,704 $ 293,650 14.0 %



Diluted EPS $ 10.08 $ 1.58 $ 11.65



Weightedaverageshares ofcommon stock 25,196 25,196 used incomputingdiluted EPS

Fiscal Year Ended February 29, 2020

As Reported

(GAAP)

Adjustments

Adjusted

(Non-GAAP)

Sales revenue, net

$

1,707,432

100.0

%

$

-

$

1,707,432

100.0

%

Cost of goods sold

972,966

57.0

%

-

972,966

57.0

%

Gross profit

734,466

43.0

%

-

734,466

43.0

%

SG&A

511,902

30.0

%

(21,271)

(4)

465,156

27.2

%

(22,929)

(5)

(2,546)

(8)

Asset impairment charges

41,000

2.4

%

(41,000)

(6)

-

-

%

Restructuring charges

3,313

0.2

%

(3,313)

(7)

-

-

%

Operating income

178,251

10.4

%

91,059

269,310

15.8

%

Non-operating income, net

394

-

%

-

394

-

%

Interest expense

12,705

0.7

%

-

12,705

0.7

%

Income before income tax

165,940

9.7

%

91,059

256,999

15.1

%

Income tax expense

13,607

0.8

%

7,821

21,428

1.3

%

Net Income

$

152,333

8.9

%

$

83,238

$

235,571

13.8

%

Diluted EPS

$

6.02

$

3.29

$

9.30

Weighted average shares of common stock used in computing diluted EPS

25,322

25,322

Fiscal Year Ended February 29, 2020

As Reported Adjusted Adjustments (GAAP) (Non-GAAP)

Sales $ 1,707,432 100.0 % $ - $ 1,707,432 100.0 %revenue, net

Cost of goods 972,966 57.0 % - 972,966 57.0 %sold

Gross profit 734,466 43.0 % - 734,466 43.0 %

SG&A 511,902 30.0 % (21,271) (4) 465,156 27.2 %

(22,929) (5)

(2,546) (8)

Assetimpairment 41,000 2.4 % (41,000) (6) - - %charges

Restructuring 3,313 0.2 % (3,313) (7) - - %charges

Operating 178,251 10.4 % 91,059 269,310 15.8 %income

Non-operating 394 - % - 394 - %income, net

Interest 12,705 0.7 % - 12,705 0.7 %expense

Income before 165,940 9.7 % 91,059 256,999 15.1 %income tax

Income tax 13,607 0.8 % 7,821 21,428 1.3 %expense

Net Income $ 152,333 8.9 % $ 83,238 $ 235,571 13.8 %



Diluted EPS $ 6.02 $ 3.29 $ 9.30



Weightedaverageshares ofcommon stock 25,322 25,322 used incomputingdiluted EPS

Consolidated and Segment Net Sales Revenue

(Unaudited) (in thousands)

Three Months Ended Last Day of February,

Housewares

Health & Home

Beauty

Total

Fiscal 2020 sales revenue, net

$

144,948

$

185,854

$

111,563

$

442,365

Organic business (1)

17,113

40,648

(3,836)

53,925

Impact of foreign currency

402

2,121

195

2,718

Acquisition (2)

-

-

10,367

10,367

Change in sales revenue, net

17,515

42,769

6,726

67,010

Fiscal 2021 sales revenue, net

$

162,463

$

228,623

$

118,289

$

509,375

Total net sales revenue growth (decline)

12.1

%

23.0

%

6.0

%

15.1

%

Organic business

11.8

%

21.9

%

(3.4)

%

12.2

%

Impact of foreign currency

0.3

%

1.1

%

0.2

%

0.6

%

Acquisition

-

%

-

%

9.3

%

2.3

%

Consolidated and Segment Net Sales Revenue

(Unaudited) (in thousands)

Three Months Ended Last Day of February,

Housewares Health & Beauty Total Home

Fiscal 2020 sales revenue, $ 144,948 $ 185,854 $ 111,563 $ 442,365 net

Organic business (1) 17,113 40,648 (3,836) 53,925

Impact of foreign currency 402 2,121 195 2,718

Acquisition (2) - - 10,367 10,367

Change in sales revenue, net 17,515 42,769 6,726 67,010

Fiscal 2021 sales revenue, $ 162,463 $ 228,623 $ 118,289 $ 509,375 net



Total net sales revenue 12.1 % 23.0 % 6.0 % 15.1 %growth (decline)

Organic business 11.8 % 21.9 % (3.4) % 12.2 %

Impact of foreign currency 0.3 % 1.1 % 0.2 % 0.6 %

Acquisition - % - % 9.3 % 2.3 %

Fiscal Year Ended Last Day of February,

Housewares

Health & Home

Beauty

Total

Fiscal 2020 sales revenue, net

$

640,965

$

685,397

$

381,070

$

1,707,432

Organic business (1)

85,916

202,786

57,110

345,812

Impact of foreign currency

473

2,008

(2,926)

(445)

Acquisition (2)

-

-

46,000

46,000

Change in sales revenue, net

86,389

204,794

100,184

391,367

Fiscal 2021 sales revenue, net

$

727,354

$

890,191

$

481,254

$

2,098,799

Total net sales revenue growth (decline)

13.5

%

29.9

%

26.3

%

22.9

%

Organic business

13.4

%

29.6

%

15.0

%

20.3

%

Impact of foreign currency

0.1

%

0.3

%

(0.8)

%

-

%

Acquisition

-

%

-

%

12.1

%

2.7

%

Fiscal Year Ended Last Day of February,

Housewares Health & Beauty Total Home

Fiscal 2020 sales $ 640,965 $ 685,397 $ 381,070 $ 1,707,432 revenue, net

Organic business (1) 85,916 202,786 57,110 345,812

Impact of foreign 473 2,008 (2,926) (445) currency

Acquisition (2) - - 46,000 46,000

Change in sales 86,389 204,794 100,184 391,367 revenue, net

Fiscal 2021 sales $ 727,354 $ 890,191 $ 481,254 $ 2,098,799 revenue, net



Total net sales revenue 13.5 % 29.9 % 26.3 % 22.9 %growth (decline)

Organic business 13.4 % 29.6 % 15.0 % 20.3 %

Impact of foreign 0.1 % 0.3 % (0.8) % - %currency

Acquisition - % - % 12.1 % 2.7 %

Leadership Brand and Other Net Sales Revenue (2)

(Unaudited) (in thousands)

Three Months Ended Last Day of February,

2021

2020

$ Change

% Change

Leadership Brand sales revenue, net (9)

$

417,931

$

347,713

$

70,218

20.2

%

All other sales revenue, net

91,444

94,652

(3,208)

(3.4)

%

Total sales revenue, net

$

509,375

$

442,365

$

67,010

15.1

%

Leadership Brand and Other Net Sales Revenue (2)

(Unaudited) (in thousands)

Three Months Ended Last Day of February,

2021 2020 $ Change % Change

Leadership Brand sales revenue, $ 417,931 $ 347,713 $ 70,218 20.2 %net (9)

All other sales revenue, net 91,444 94,652 (3,208) (3.4) %

Total sales revenue, net $ 509,375 $ 442,365 $ 67,010 15.1 %

Fiscal Year Ended Last Day of February,

2021

2020

$ Change

% Change

Leadership Brand sales revenue, net (9)

$

1,706,545

$

1,360,059

$

346,486

25.5

%

All other sales revenue, net

392,254

347,373

44,881

12.9

%

Total sales revenue, net

$

2,098,799

$

1,707,432

$

391,367

22.9

%

Fiscal Year Ended Last Day of February,

2021 2020 $ Change % Change

Leadership Brand sales $ 1,706,545 $ 1,360,059 $ 346,486 25.5 %revenue, net (9)

All other sales revenue, net 392,254 347,373 44,881 12.9 %

Total sales revenue, net $ 2,098,799 $ 1,707,432 $ 391,367 22.9 %

Consolidated and Segment Net Sales from Core and Non-Core Business (3)

(Unaudited) (in thousands)

Three Months Ended Last Day of February,

Housewares

Health & Home

Beauty

Total

Fiscal 2020 sales revenue, net

$

144,948

$

185,854

$

111,563

$

442,365

Core business

17,515

42,769

11,534

71,818

Non-Core business (Personal Care)

-

-

(4,808)

(4,808)

Change in sales revenue, net

17,515

42,769

6,726

67,010

Fiscal 2021 sales revenue, net

$

162,463

$

228,623

$

118,289

$

509,375

Total net sales revenue growth (decline)

12.1

%

23.0

%

6.0

%

15.1

%

Core business

12.1

%

23.0

%

10.3

%

16.2

%

Non-Core business (Personal Care)

-

%

-

%

(4.3)

%

(1.1)

%

Consolidated and Segment Net Sales from Core and Non-Core Business (3)

(Unaudited) (in thousands)

Three Months Ended Last Day of February,

Housewares Health & Beauty Total Home

Fiscal 2020 sales revenue, $ 144,948 $ 185,854 $ 111,563 $ 442,365 net

Core business 17,515 42,769 11,534 71,818

Non-Core business (Personal - - (4,808) (4,808) Care)

Change in sales revenue, net 17,515 42,769 6,726 67,010

Fiscal 2021 sales revenue, $ 162,463 $ 228,623 $ 118,289 $ 509,375 net



Total net sales revenue 12.1 % 23.0 % 6.0 % 15.1 %growth (decline)

Core business 12.1 % 23.0 % 10.3 % 16.2 %

Non-Core business (Personal - % - % (4.3) % (1.1) %Care)

Fiscal Year Ended Last Day of February,

Housewares

Health & Home

Beauty

Total

Fiscal 2020 sales revenue, net

$

640,965

$

685,397

$

381,070

$

1,707,432

Core business

86,389

204,794

114,176

405,359

Non-Core business (Personal Care)

-

-

(13,992)

(13,992)

Change in sales revenue, net

86,389

204,794

100,184

391,367

Fiscal 2021 sales revenue, net

$

727,354

$

890,191

$

481,254

$

2,098,799

Total net sales revenue growth (decline)

13.5

%

29.9

%

26.3

%

22.9

%

Core business

13.5

%

29.9

%

30.0

%

23.7

%

Non-Core business (Personal Care)

-

%

-

%

(3.7)

%

(0.8)

%

Fiscal Year Ended Last Day of February,

Housewares Health & Beauty Total Home

Fiscal 2020 sales $ 640,965 $ 685,397 $ 381,070 $ 1,707,432 revenue, net

Core business 86,389 204,794 114,176 405,359

Non-Core business - - (13,992) (13,992) (Personal Care)

Change in sales 86,389 204,794 100,184 391,367 revenue, net

Fiscal 2021 sales $ 727,354 $ 890,191 $ 481,254 $ 2,098,799 revenue, net



Total net sales revenue 13.5 % 29.9 % 26.3 % 22.9 %growth (decline)

Core business 13.5 % 29.9 % 30.0 % 23.7 %

Non-Core business - % - % (3.7) % (0.8) %(Personal Care)

Reconciliation of Non-GAAP Financial Measures - GAAP Operating Income

to Adjusted Operating Income (Non-GAAP) (10)

(Unaudited) (in thousands)

Three Months Ended February 28, 2021

Housewares

Health & Home

Beauty (2)

Total

Operating income (loss), as reported (GAAP)

$

16,193

10.0

%

$

(1,679)

(0.7)

%

$

10,011

8.5

%

$

24,525

4.8

%

Asset impairment charges

-

-

%

-

-

%

8,452

7.1

%

8,452

1.7

%

Restructuring charges

(2)

-

%

(6)

-

%

3

-

%

(5)

-

%

Subtotal

16,191

10.0

%

(1,685)

(0.7)

%

18,466

15.6

%

32,972

6.5

%

Amortization of intangible assets

514

0.3

%

1,196

0.5

%

2,406

2.0

%

4,116

0.8

%

Non-cash share-based compensation

2,254

1.4

%

2,025

0.9

%

1,485

1.3

%

5,764

1.1

%

Adjusted operating income (non-GAAP)

$

18,959

11.7

%

$

1,536

0.7

%

$

22,357

18.9

%

$

42,852

8.4

%

Reconciliation of Non-GAAP Financial Measures - GAAP Operating Income

to Adjusted Operating Income (Non-GAAP) (10)

(Unaudited) (in thousands)

Three Months Ended February 28, 2021

Housewares Health & Home Beauty (2) Total

Operating income(loss), as $ 16,193 10.0 % $ (1,679) (0.7) % $ 10,011 8.5 % $ 24,525 4.8 %reported (GAAP)

Asset impairment - - % - - % 8,452 7.1 % 8,452 1.7 %charges

Restructuring (2) - % (6) - % 3 - % (5) - %charges

Subtotal 16,191 10.0 % (1,685) (0.7) % 18,466 15.6 % 32,972 6.5 %

Amortization ofintangible 514 0.3 % 1,196 0.5 % 2,406 2.0 % 4,116 0.8 %assets

Non-cashshare-based 2,254 1.4 % 2,025 0.9 % 1,485 1.3 % 5,764 1.1 %compensation

Adjustedoperating income $ 18,959 11.7 % $ 1,536 0.7 % $ 22,357 18.9 % $ 42,852 8.4 %(non-GAAP)

Three Months Ended February 29, 2020

Housewares

Health & Home

Beauty (2)

Total

Operating income (loss), as reported (GAAP)

$

13,965

9.6

%

$

16,330

8.8

%

$

(33,040)

(29.6)

%

$

(2,745)

(0.6)

%

Acquisition-related expenses (8)

-

-

%

-

-

%

1,071

1.0

%

1,071

0.2

%

Asset impairment charges

-

-

%

-

-

%

41,000

36.8

%

41,000

9.3

%

Restructuring charges

1,261

0.9

%

93

0.1

%

898

0.8

%

2,252

0.5

%

Subtotal

15,226

10.5

%

16,423

8.8

%

9,929

8.9

%

41,578

9.4

%

Amortization of intangible assets

543

0.4

%

2,451

1.3

%

5,148

4.6

%

8,142

1.8

%

Non-cash share-based compensation

1,365

0.9

%

1,878

1.0

%

943

0.8

%

4,186

0.9

%

Adjusted operating income (non-GAAP)

$

17,134

11.8

%

$

20,752

11.2

%

$

16,020

14.4

%

$

53,906

12.2

%

Three Months Ended February 29, 2020

Housewares Health & Home Beauty (2) Total

Operating income (loss), as $ 13,965 9.6 % $ 16,330 8.8 % $ (33,040) (29.6) % $ (2,745) (0.6) %reported (GAAP)

Acquisition-related expenses (8) - - % - - % 1,071 1.0 % 1,071 0.2 %

Asset impairment charges - - % - - % 41,000 36.8 % 41,000 9.3 %

Restructuring charges 1,261 0.9 % 93 0.1 % 898 0.8 % 2,252 0.5 %

Subtotal 15,226 10.5 % 16,423 8.8 % 9,929 8.9 % 41,578 9.4 %

Amortization of intangible 543 0.4 % 2,451 1.3 % 5,148 4.6 % 8,142 1.8 %assets

Non-cash share-based 1,365 0.9 % 1,878 1.0 % 943 0.8 % 4,186 0.9 %compensation

Adjusted operating income $ 17,134 11.8 % $ 20,752 11.2 % $ 16,020 14.4 % $ 53,906 12.2 %(non-GAAP)

Fiscal Year Ended February 28, 2021

Housewares

Health & Home

Beauty (2)

Total

Operating income, as reported (GAAP)

$

122,487

16.8

%

$

94,103

10.6

%

$

64,898

13.5

%

$

281,488

13.4

%

Asset impairment charges

-

-

%

-

-

%

8,452

1.8

%

8,452

0.4

%

Restructuring charges

249

-

%

(6)

-

%

107

-

%

350

-

%

Subtotal

122,736

16.9

%

94,097

10.6

%

73,457

15.3

%

290,290

13.8

%

Amortization of intangible assets

2,055

0.3

%

8,611

1.0

%

6,977

1.4

%

17,643

0.8

%

Non-cash share-based compensation

10,278

1.4

%

9,191

1.0

%

6,949

1.4

%

26,418

1.3

%

Adjusted operating income (non-GAAP)

$

135,069

18.6

%

$

111,899

12.6

%

$

87,383

18.2

%

$

334,351

15.9

%

Fiscal Year Ended February 28, 2021

Housewares Health & Home Beauty (2) Total

Operatingincome, as $ 122,487 16.8 % $ 94,103 10.6 % $ 64,898 13.5 % $ 281,488 13.4 %reported (GAAP)

Asset impairment - - % - - % 8,452 1.8 % 8,452 0.4 %charges

Restructuring 249 - % (6) - % 107 - % 350 - %charges

Subtotal 122,736 16.9 % 94,097 10.6 % 73,457 15.3 % 290,290 13.8 %

Amortization ofintangible 2,055 0.3 % 8,611 1.0 % 6,977 1.4 % 17,643 0.8 %assets

Non-cashshare-based 10,278 1.4 % 9,191 1.0 % 6,949 1.4 % 26,418 1.3 %compensation

Adjustedoperating income $ 135,069 18.6 % $ 111,899 12.6 % $ 87,383 18.2 % $ 334,351 15.9 %(non-GAAP)

Fiscal Year Ended February 29, 2020

Housewares

Health & Home

Beauty (2)

Total

Operating income (loss), as reported (GAAP)

$

123,135

19.2

%

$

68,166

9.9

%

$

(13,050)

(3.4)

%

$

178,251

10.4

%

Acquisition-related expenses (8)

-

-

%

-

-

%

2,546

0.7

%

2,546

0.1

%

Asset impairment charges

-

-

%

-

-

%

41,000

10.8

%

41,000

2.4

%

Restructuring charges

1,351

0.2

%

93

-

%

1,869

0.5

%

3,313

0.2

%

Subtotal

124,486

19.4

%

68,259

10.0

%

32,365

8.5

%

225,110

13.2

%

Amortization of intangible assets

2,055

0.3

%

10,539

1.5

%

8,677

2.3

%

21,271

1.2

%

Non-cash share-based compensation

7,218

1.1

%

9,717

1.4

%

5,994

1.6

%

22,929

1.3

%

Adjusted operating income (non-GAAP)

$

133,759

20.9

%

$

88,515

12.9

%

$

47,036

12.3

%

$

269,310

15.8

%

Fiscal Year Ended February 29, 2020

Housewares Health & Home Beauty (2) Total

Operating income (loss), as $ 123,135 19.2 % $ 68,166 9.9 % $ (13,050) (3.4) % $ 178,251 10.4 %reported (GAAP)

Acquisition-related expenses (8) - - % - - % 2,546 0.7 % 2,546 0.1 %

Asset impairment charges - - % - - % 41,000 10.8 % 41,000 2.4 %

Restructuring charges 1,351 0.2 % 93 - % 1,869 0.5 % 3,313 0.2 %

Subtotal 124,486 19.4 % 68,259 10.0 % 32,365 8.5 % 225,110 13.2 %

Amortization of intangible 2,055 0.3 % 10,539 1.5 % 8,677 2.3 % 21,271 1.2 %assets

Non-cash share-based 7,218 1.1 % 9,717 1.4 % 5,994 1.6 % 22,929 1.3 %compensation

Adjusted operating income $ 133,759 20.9 % $ 88,515 12.9 % $ 47,036 12.3 % $ 269,310 15.8 %(non-GAAP)

Reconciliation of Non-GAAP Financial Measures - EBITDA

(Earnings Before Interest, Taxes, Depreciation and Amortization) and Adjusted EBITDA (10)

(Unaudited) (in thousands)

Three Months Ended February 28, 2021

Housewares

Health & Home

Beauty (2)

Total

Operating income (loss), as reported (GAAP)

$

16,193

$

(1,679)

$

10,011

$

24,525

Depreciation and amortization

2,590

3,122

4,011

9,723

Non-operating income, net

-

-

119

119

EBITDA (non-GAAP)

18,783

1,443

14,141

34,367

Add: Restructuring charges

(2)

(6)

3

(5)

Asset impairment charges

-

-

8,452

8,452

Non-cash share-based compensation

2,254

2,025

1,485

5,764

Adjusted EBITDA (non-GAAP)

$

21,035

$

3,462

$

24,081

$

48,578

Reconciliation of Non-GAAP Financial Measures - EBITDA

(Earnings Before Interest, Taxes, Depreciation and Amortization) and AdjustedEBITDA (10)

(Unaudited) (in thousands)

Three Months Ended February 28, 2021

Housewares Health & Beauty (2) Total Home

Operating income (loss), as $ 16,193 $ (1,679) $ 10,011 $ 24,525 reported (GAAP)

Depreciation and amortization 2,590 3,122 4,011 9,723

Non-operating income, net - - 119 119

EBITDA (non-GAAP) 18,783 1,443 14,141 34,367

Add: Restructuring charges (2) (6) 3 (5)

Asset impairment charges - - 8,452 8,452

Non-cash share-based 2,254 2,025 1,485 5,764 compensation

Adjusted EBITDA (non-GAAP) $ 21,035 $ 3,462 $ 24,081 $ 48,578

Three Months Ended February 29, 2020

Housewares

Health & Home

Beauty (2)

Total

Operating income (loss), as reported (GAAP)

$

13,965

$

16,330

$

(33,040)

$

(2,745)

Depreciation and amortization

2,006

3,791

6,736

12,533

Non-operating income, net

-

-

81

81

EBITDA (non-GAAP)

15,971

20,121

(26,223)

9,869

Add: Acquisition-related expenses (8)

-

-

1,071

1,071

Restructuring charges

1,261

93

898

2,252

Asset impairment charges

-

-

41,000

41,000

Non-cash share-based compensation

1,365

1,878

943

4,186

Adjusted EBITDA (non-GAAP)

$

18,597

$

22,092

$

17,689

$

58,378

Three Months Ended February 29, 2020

Housewares Health & Beauty (2) Total Home

Operating income (loss), $ 13,965 $ 16,330 $ (33,040) $ (2,745) as reported (GAAP)

Depreciation and 2,006 3,791 6,736 12,533 amortization

Non-operating income, net - - 81 81

EBITDA (non-GAAP) 15,971 20,121 (26,223) 9,869

Add: Acquisition-related - - 1,071 1,071 expenses (8)

Restructuring charges 1,261 93 898 2,252

Asset impairment charges - - 41,000 41,000

Non-cash share-based 1,365 1,878 943 4,186 compensation

Adjusted EBITDA (non-GAAP) $ 18,597 $ 22,092 $ 17,689 $ 58,378

Fiscal Year Ended February 28, 2021

Housewares

Health & Home

Beauty (2)

Total

Operating income, as reported (GAAP)

$

122,487

$

94,103

$

64,898

$

281,488

Depreciation and amortization

9,333

15,453

12,932

37,718

Non-operating income, net

-

-

559

559

EBITDA (non-GAAP)

131,820

109,556

78,389

319,765

Add: Restructuring charges

249

(6)

107

350

Asset impairment charges

-

-

8,452

8,452

Non-cash share-based compensation

10,278

9,191

6,949

26,418

Adjusted EBITDA (non-GAAP)

$

142,347

$

118,741

$

93,897

$

354,985

Fiscal Year Ended February 28, 2021

Housewares Health & Beauty (2) Total Home

Operating income, as reported $ 122,487 $ 94,103 $ 64,898 $ 281,488 (GAAP)

Depreciation and amortization 9,333 15,453 12,932 37,718

Non-operating income, net - - 559 559

EBITDA (non-GAAP) 131,820 109,556 78,389 319,765

Add: Restructuring charges 249 (6) 107 350

Asset impairment charges - - 8,452 8,452

Non-cash share-based 10,278 9,191 6,949 26,418 compensation

Adjusted EBITDA (non-GAAP) $ 142,347 $ 118,741 $ 93,897 $ 354,985

Fiscal Year Ended February 29, 2020

Housewares

Health & Home

Beauty (2)

Total

Operating income (loss), as reported (GAAP)

$

123,135

$

68,166

$

(13,050)

$

178,251

Depreciation and amortization

7,298

16,113

13,998

37,409

Non-operating income, net

-

-

394

394

EBITDA (non-GAAP)

130,433

84,279

1,342

216,054

Add: Acquisition-related expenses (8)

-

-

2,546

2,546

Restructuring charges

1,351

93

1,869

3,313

Asset impairment charges

-

-

41,000

41,000

Non-cash share-based compensation

7,218

9,717

5,994

22,929

Adjusted EBITDA (non-GAAP)

$

139,002

$

94,089

$

52,751

$

285,842

Fiscal Year Ended February 29, 2020

Health & Home Beauty (2) Total Housewares

Operating income (loss), $ 123,135 $ 68,166 $ (13,050) $ 178,251 as reported (GAAP)

Depreciation and 7,298 16,113 13,998 37,409 amortization

Non-operating income, net - - 394 394

EBITDA (non-GAAP) 130,433 84,279 1,342 216,054

Add: Acquisition-related - - 2,546 2,546 expenses (8)

Restructuring charges 1,351 93 1,869 3,313

Asset impairment charges - - 41,000 41,000

Non-cash share-based 7,218 9,717 5,994 22,929 compensation

Adjusted EBITDA (non-GAAP) $ 139,002 $ 94,089 $ 52,751 $ 285,842

Reconciliation of GAAP Income (Loss) and Diluted EPS to

Adjusted Income and Adjusted Diluted EPS (Non-GAAP) (10)

(Unaudited) (in thousands, except per share data)

Three Months Ended February 28, 2021

Income

Diluted EPS

Before Tax

Tax

Net of Tax

Before Tax

Tax

Net of Tax

As reported (GAAP)

$

21,595

$

(577)

$

22,172

$

0.87

$

(0.02)

$

0.90

Asset impairment charges

8,452

1,009

7,443

0.34

0.04

0.30

Restructuring charges

(5)

-

(5)

-

-

-

Subtotal

30,042

432

29,610

1.21

0.02

1.20

Amortization of intangible assets

4,116

214

3,902

0.17

0.01

0.16

Non-cash share-based compensation

5,764

520

5,244

0.23

0.02

0.21

Adjusted (non-GAAP)

$

39,922

$

1,166

$

38,756

$

1.61

$

0.05

$

1.57

Weighted average shares of common stock used in computing diluted EPS

24,737

Reconciliation of GAAP Income (Loss) and Diluted EPS to

Adjusted Income and Adjusted Diluted EPS (Non-GAAP) (10)

(Unaudited) (in thousands, except per share data)

Three Months Ended February 28, 2021

Income Diluted EPS

Before Tax Tax Net of Tax Before Tax Net of Tax Tax

As reported $ 21,595 $ (577) $ 22,172 $ 0.87 $ (0.02) $ 0.90 (GAAP)

Assetimpairment 8,452 1,009 7,443 0.34 0.04 0.30 charges

Restructuring (5) - (5) - - - charges

Subtotal 30,042 432 29,610 1.21 0.02 1.20

Amortizationof intangible 4,116 214 3,902 0.17 0.01 0.16 assets

Non-cashshare-based 5,764 520 5,244 0.23 0.02 0.21 compensation

Adjusted $ 39,922 $ 1,166 $ 38,756 $ 1.61 $ 0.05 $ 1.57 (non-GAAP)



Weighted average shares of common stock used in computing diluted EPS 24,737

Three Months Ended February 29, 2020

(Loss) Income

Diluted EPS

Before Tax

Tax

Net of Tax

Before Tax

Tax

Net of Tax

As reported (GAAP)

$

(6,078)

$

(2,923)

$

(3,155)

$

(0.24)

$

(0.12)

$

(0.13)

Acquisition-related expenses (8)

1,071

16

1,055

0.04

-

0.04

Asset impairment charges

41,000

4,574

36,426

1.61

0.18

1.43

Restructuring charges

2,252

93

2,159

0.09

-

0.08

Subtotal

38,245

1,760

36,485

1.51

0.07

1.44

Amortization of intangible assets

8,142

624

7,518

0.32

0.02

0.30

Non-cash share-based compensation

4,186

369

3,817

0.16

0.01

0.15

Adjusted (non-GAAP)

$

50,573

$

2,753

$

47,820

$

1.99

$

0.11

$

1.88

Weighted average shares of common stock used in computing diluted EPS

25,403

Three Months Ended February 29, 2020

(Loss) Income Diluted EPS

Before Tax Tax Net of Tax Before Tax Tax Net of Tax

As reported (GAAP) $ (6,078) $ (2,923) $ (3,155) $ (0.24) $ (0.12) $ (0.13)

Acquisition-related 1,071 16 1,055 0.04 - 0.04 expenses (8)

Asset impairment charges 41,000 4,574 36,426 1.61 0.18 1.43

Restructuring charges 2,252 93 2,159 0.09 - 0.08

Subtotal 38,245 1,760 36,485 1.51 0.07 1.44

Amortization of intangible 8,142 624 7,518 0.32 0.02 0.30 assets

Non-cash share-based 4,186 369 3,817 0.16 0.01 0.15 compensation

Adjusted (non-GAAP) $ 50,573 $ 2,753 $ 47,820 $ 1.99 $ 0.11 $ 1.88



Weighted average shares of common stock used in computing diluted EPS 25,403

Fiscal Year Ended February 28, 2021

Income

Diluted EPS

Before Tax

Tax

Net of Tax

Before Tax

Tax

Net of Tax

As reported (GAAP)

$

269,430

$

15,484

$

253,946

$

10.69

$

0.61

$

10.08

Asset impairment charges

8,452

1,009

7,443

0.34

0.04

0.30

Restructuring charges

350

2

348

0.01

-

0.01

Tax reform

-

9,357

(9,357)

-

0.37

(0.37)

Subtotal

278,232

25,852

252,380

11.04

1.03

10.02

Amortization of intangible assets

17,643

865

16,778

0.70

0.03

0.67

Non-cash share-based compensation

26,418

1,926

24,492

1.05

0.08

0.97

Adjusted (non-GAAP)

$

322,293

$

28,643

$

293,650

$

12.79

$

1.14

$

11.65

Weighted average shares of common stock used in computing diluted EPS

25,196

Fiscal Year Ended February 28, 2021

Income Diluted EPS

Before Tax Tax Net of Tax Before Tax Net of Tax Tax

As reported $ 269,430 $ 15,484 $ 253,946 $ 10.69 $ 0.61 $ 10.08 (GAAP)

Assetimpairment 8,452 1,009 7,443 0.34 0.04 0.30 charges

Restructuring 350 2 348 0.01 - 0.01 charges

Tax reform - 9,357 (9,357) - 0.37 (0.37)

Subtotal 278,232 25,852 252,380 11.04 1.03 10.02

Amortizationof intangible 17,643 865 16,778 0.70 0.03 0.67 assets

Non-cashshare-based 26,418 1,926 24,492 1.05 0.08 0.97 compensation

Adjusted $ 322,293 $ 28,643 $ 293,650 $ 12.79 $ 1.14 $ 11.65 (non-GAAP)



Weighted average shares of common stock used in computing diluted EPS 25,196

Fiscal Year Ended February 29, 2020

Income

Diluted EPS

Before Tax

Tax

Net of Tax

Before Tax

Tax

Net of Tax

As reported (GAAP)

$

165,940

$

13,607

$

152,333

$

6.55

$

0.54

$

6.02

Acquisition-related expenses (8)

2,546

38

2,508

0.10

-

0.10

Asset impairment charges

41,000

4,574

36,426

1.62

0.18

1.44

Restructuring charges

3,313

161

3,152

0.13

0.01

0.12

Subtotal

212,799

18,380

194,419

8.40

0.73

7.68

Amortization of intangible assets

21,271

1,245

20,026

0.84

0.05

0.79

Non-cash share-based compensation

22,929

1,803

21,126

0.91

0.07

0.83

Adjusted (non-GAAP)

$

256,999

$

21,428

$

235,571

$

10.15

$

0.85

$

9.30

Weighted average shares of common stock used in computing diluted EPS

25,322

Fiscal Year Ended February 29, 2020

Income Diluted EPS

Before Tax Tax Net of Tax Before Tax Net of Tax Tax

As reported (GAAP) $ 165,940 $ 13,607 $ 152,333 $ 6.55 $ 0.54 $ 6.02

Acquisition-related 2,546 38 2,508 0.10 - 0.10 expenses (8)

Asset impairment charges 41,000 4,574 36,426 1.62 0.18 1.44

Restructuring charges 3,313 161 3,152 0.13 0.01 0.12

Subtotal 212,799 18,380 194,419 8.40 0.73 7.68

Amortization of 21,271 1,245 20,026 0.84 0.05 0.79 intangible assets

Non-cash share-based 22,929 1,803 21,126 0.91 0.07 0.83 compensation

Adjusted (non-GAAP) $ 256,999 $ 21,428 $ 235,571 $ 10.15 $ 0.85 $ 9.30



Weighted average shares of common stock used in computing diluted EPS 25,322

Consolidated Core and Non-Core Net Sales and Reconciliation of Core and Non-Core Diluted EPS to Core and Non-Core Adjusted Diluted EPS (Non-GAAP) (3) (10)

(Unaudited) (in thousands, except per share data)

Three Months Ended Last Day of February,

2021

2020

$ Change

% Change

Sales revenue, net

Core

$

493,458

$

421,640

$

71,818

17.0

%

Non-Core

15,917

20,725

(4,808)

(23.2)

%

Total

$

509,375

$

442,365

$

67,010

15.1

%

Consolidated Core and Non-Core Net Sales and Reconciliation of Core andNon-Core Diluted EPS to Core and Non-Core Adjusted Diluted EPS (Non-GAAP) (3)(10)

(Unaudited) (in thousands, except per share data)

Three Months Ended Last Day of February,

2021 2020 $ Change % Change

Sales revenue, net

Core $ 493,458 $ 421,640 $ 71,818 17.0 %

Non-Core 15,917 20,725 (4,808) (23.2) %

Total $ 509,375 $ 442,365 $ 67,010 15.1 %

Three Months Ended Last Day of February,

2021

2020

$ Change

% Change

Adjusted Diluted EPS (non-GAAP)

Core

$

1.42

$

1.73

$

(0.31)

(17.9)

%

Non-Core

0.15

0.15

-

-

%

Total

$

1.57

$

1.88

$

(0.31)

(16.5)

%

Three Months Ended Last Day of February,

2021 2020 $ Change % Change

Adjusted Diluted EPS (non-GAAP)

Core $ 1.42 $ 1.73 $ (0.31) (17.9) %

Non-Core 0.15 0.15 - - %

Total $ 1.57 $ 1.88 $ (0.31) (16.5) %

Three Months Ended Last Day of February,

Core Business:

2021

2020

Diluted EPS, as reported

$

1.05

$

1.31

Acquisition-related expenses, net of tax

-

0.04

Restructuring charges, net of tax

-

0.08

Subtotal

1.05

1.43

Amortization of intangible assets, net of tax

0.16

0.15

Non-cash share-based compensation, net of tax

0.21

0.15

Adjusted Diluted EPS (non-GAAP)

$

1.42

$

1.73

Three Months Ended Last Day of February,

Non-Core Business:

2021

2020

Diluted EPS, as reported

$

(0.15)

$

(1.44)

Asset impairment charges, net of tax

0.30

1.43

Subtotal

0.15

(0.01)

Amortization of intangible assets, net of tax

-

0.15

Adjusted Diluted EPS (non-GAAP)

$

0.15

$

0.15

Diluted EPS, as reported (GAAP)

$

0.90

$

(0.13)

Three Months Ended Last Day of February,

Core Business: 2021 2020

Diluted EPS, as reported $ 1.05 $ 1.31

Acquisition-related expenses, net of tax - 0.04

Restructuring charges, net of tax - 0.08

Subtotal 1.05 1.43

Amortization of intangible assets, net of 0.16 0.15 tax

Non-cash share-based compensation, net of 0.21 0.15 tax

Adjusted Diluted EPS (non-GAAP) $ 1.42 $ 1.73



Three Months Ended Last Day of February,

Non-Core Business: 2021 2020

Diluted EPS, as reported $ (0.15) $ (1.44)

Asset impairment charges, net of tax 0.30 1.43

Subtotal 0.15 (0.01)

Amortization of intangible assets, net of - 0.15 tax

Adjusted Diluted EPS (non-GAAP) $ 0.15 $ 0.15



Diluted EPS, as reported (GAAP) $ 0.90 $ (0.13)

Consolidated Core and Non-Core Net Sales and Reconciliation of Core and Non-Core

Diluted EPS to Core and Non-Core Adjusted Diluted EPS (Non-GAAP) (3) (10)

(Unaudited) (in thousands, except per share data)

Fiscal Years Ended Last Day of February,

2021

2020

$ Change

% Change

Sales revenue, net

Core

$

2,020,453

$

1,615,094

$

405,359

25.1

%

Non-Core

78,346

92,338

(13,992)

(15.2)

%

Total

$

2,098,799

$

1,707,432

$

391,367

22.9

%

Consolidated Core and Non-Core Net Sales and Reconciliation of Core andNon-Core

Diluted EPS to Core and Non-Core Adjusted Diluted EPS (Non-GAAP) (3) (10)^

(Unaudited) (in thousands, except per share data)

Fiscal Years Ended Last Day of February,

2021 2020 $ Change % Change

Sales revenue, net

Core $ 2,020,453 $ 1,615,094 $ 405,359 25.1 %

Non-Core 78,346 92,338 (13,992) (15.2) %

Total $ 2,098,799 $ 1,707,432 $ 391,367 22.9 %

Fiscal Years Ended Last Day of February,

2021

2020

$ Change

% Change

Adjusted Diluted EPS (non-GAAP)

Core

$

11.03

$

8.72

$

2.31

26.5

%

Non-Core

0.62

0.58

0.04

6.9

%

Total

$

11.65

$

9.30

$

2.35

25.3

%

Fiscal Years Ended Last Day of February,

2021 2020 $ Change % Change

Adjusted Diluted EPS (non-GAAP)

Core $ 11.03 $ 8.72 $ 2.31 26.5 %

Non-Core 0.62 0.58 0.04 6.9 %

Total $ 11.65 $ 9.30 $ 2.35 25.3 %

Fiscal Years Ended Last Day of February,

Core Business:

2021

2020

Diluted EPS, as reported

$

9.76

$

7.16

Acquisition-related expenses, net of tax

-

0.10

Restructuring charges, net of tax

0.01

0.11

Tax Reform

(0.37)

-

Subtotal

9.40

7.37

Amortization of intangible assets, net of tax

0.67

0.53

Non-cash share-based compensation, net of tax

0.97

0.82

Adjusted Diluted EPS (non-GAAP)

$

11.03

$

8.72

Fiscal Years Ended Last Day of February,

Non-Core Business:

2021

2020

Diluted EPS, as reported

$

0.32

$

(1.14)

Asset impairment charges, net of tax

0.30

1.44

Restructuring charges, net of tax

-

0.01

Subtotal

0.62

0.31

Amortization of intangible assets, net of tax

-

0.26

Non-cash share-based compensation, net of tax

-

0.01

Adjusted Diluted EPS (non-GAAP)

$

0.62

$

0.58

Diluted EPS, as reported (GAAP)

$

10.08

$

6.02

Fiscal Years Ended Last Day of February,

Core Business: 2021 2020

Diluted EPS, as reported $ 9.76 $ 7.16

Acquisition-related expenses, net of tax - 0.10

Restructuring charges, net of tax 0.01 0.11

Tax Reform (0.37) -

Subtotal 9.40 7.37

Amortization of intangible assets, net of 0.67 0.53 tax

Non-cash share-based compensation, net of 0.97 0.82 tax

Adjusted Diluted EPS (non-GAAP) $ 11.03 $ 8.72



Fiscal Years Ended Last Day of February,

Non-Core Business: 2021 2020

Diluted EPS, as reported $ 0.32 $ (1.14)

Asset impairment charges, net of tax 0.30 1.44

Restructuring charges, net of tax - 0.01

Subtotal 0.62 0.31

Amortization of intangible assets, net of - 0.26 tax

Non-cash share-based compensation, net of - 0.01 tax

Adjusted Diluted EPS (non-GAAP) $ 0.62 $ 0.58



Diluted EPS, as reported (GAAP) $ 10.08 $ 6.02

Selected Consolidated Balance Sheet, Cash Flow and Liquidity Information

(Unaudited) (in thousands)

Last Day of February,

2021

2020

Balance Sheet:

Cash and cash equivalents

$

45,120

$

24,467

Receivables, net

382,449

348,023

Inventory, net

481,611

256,311

Assets held for sale

39,867

44,806

Total assets, current

971,937

682,836

Total assets

2,263,488

1,903,883

Total liabilities, current

614,892

338,896

Total long-term liabilities

409,249

403,264

Total debt

343,630

339,305

Stockholders' equity

1,239,347

1,161,723

Liquidity:

Working capital

$

357,045

$

343,940

Selected Consolidated Balance Sheet, Cash Flow and Liquidity Information

(Unaudited) (in thousands)

Last Day of February,

2021 2020

Balance Sheet:

Cash and cash equivalents $ 45,120 $ 24,467

Receivables, net 382,449 348,023

Inventory, net 481,611 256,311

Assets held for sale 39,867 44,806

Total assets, current 971,937 682,836

Total assets 2,263,488 1,903,883

Total liabilities, current 614,892 338,896

Total long-term liabilities 409,249 403,264

Total debt 343,630 339,305

Stockholders' equity 1,239,347 1,161,723

Liquidity:

Working capital $ 357,045 $ 343,940

Fiscal Years Ended

Last Day of February,

2021

2020

Cash Flow:

Depreciation and amortization

$

37,718

$

37,409

Net cash provided by operating activities

314,106

271,293

Capital and intangible asset expenditures

98,668

17,759

Net debt proceeds

7,100

16,900

Payments for repurchases of common stock

203,294

10,169

Fiscal Years Ended Last Day of February,

2021 2020

Cash Flow:

Depreciation and amortization $ 37,718 $ 37,409

Net cash provided by operating activities 314,106 271,293

Capital and intangible asset expenditures 98,668 17,759

Net debt proceeds 7,100 16,900

Payments for repurchases of common stock 203,294 10,169

Reconciliation of GAAP Net Cash Provided by Operating Activities

to Free Cash Flow (Non-GAAP) (10)

(Unaudited) (in thousands)

Fiscal Years Ended

Last Day of February,

2021

2020

Net cash provided by operating activities (GAAP)

$

314,106

$

271,293

Less: Capital and intangible asset expenditures

(98,668)

(17,759)

Free cash flow (non-GAAP)

$

215,438

$

253,534

HELEN OF TROY LIMITED AND SUBSIDIARIES

Notes to Press Release

* Organic business refers to net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand is acquired, excluding the impact that foreign currency remeasurement had on reported net sales revenue. Net sales revenue from internally developed brands or product lines is considered Organic business activity. * On January 23, 2020, we completed the acquisition of Drybar Products. As such, fiscal 2020 includes approximately five weeks of operating results from Drybar Products and fiscal 2021 includes a full year of operating results. Drybar Products sales prior to the first annual anniversary of the acquisition are reported in Acquisition. Sales from Drybar Products subsequent to the first annual anniversary of the acquisition are reported in Organic business. * The Company defines Core business as strategic business that it expects to be an ongoing part of its operations, and Non-Core business as business or assets (including assets held for sale) that it expects to divest within a year of its designation as Non-Core. * Amortization of intangible assets. * Non-cash share-based compensation. * Non-cash asset impairment charges related to goodwill and intangible assets. The impairment charges were related to assets of the Personal Care business classified as held for sale within the Beauty segment. * Charges incurred in conjunction with the Company's restructuring plan (Project Refuel). * Acquisition-related expense associated with the definitive agreement to acquire Drybar Products LLC are included in SG&A for the three- and twelve-month periods ended February 29, 2020. * Leadership Brand net sales consists of revenue from the OXO, Honeywell, Braun, PUR, Hydro Flask, Vicks, Hot Tools and Drybar brands. * This press release contains non-GAAP financial measures. Adjusted Operating Income, Adjusted Operating Margin, Adjusted Income, Adjusted Diluted EPS, Core and Non-Core Adjusted Diluted EPS, EBITDA, Adjusted EBITDA, and Free Cash Flow ("Non-GAAP Financial Measures") that are discussed in the accompanying press release or in the preceding tables may be considered non-GAAP financial information as contemplated by SEC Regulation G, Rule 100. Accordingly, the Company is providing the preceding tables that reconcile these measures to their corresponding GAAP-based measures. The Company believes that these non-GAAP measures provide useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations. The Company believes that these non-GAAP financial measures, in combination with the Company's financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of certain charges and benefits on applicable income, margin and earnings per share measures. The Company also believes that these non-GAAP measures facilitate a more direct comparison of the Company's performance with its competitors. The Company further believes that including the excluded charges and benefits would not accurately reflect the underlying performance of the Company's operations for the period in which the charges and benefits are incurred, even though such charges and benefits may be incurred and reflected in the Company's GAAP financial results in the near future. The material limitation associated with the use of the non-GAAP measures is that the non-GAAP measures do not reflect the full economic impact of the Company's activities. These non-GAAP measures are not prepared in accordance with GAAP, are not an alternative to GAAP financial information, and may be calculated differently than non-GAAP financial information disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP information. View source version on businesswire.com: https://www.businesswire.com/news/home/20210428005265/en/

CONTACT: Investor Contact: Helen of Troy Limited Anne Rakunas, Director, External Communications (915) 225-4841 ICR, Inc. Allison Malkin, Partner (203) 682-8200